<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02331199</url>
  </required_header>
  <id_info>
    <org_study_id>preterm 1</org_study_id>
    <nct_id>NCT02331199</nct_id>
  </id_info>
  <brief_title>Comparison Between Amniotic Fluid Lamellar Body Count and Fetal Pulmonary Artery Doppler Indices in Predicting Fetal Lung Maturity</brief_title>
  <official_title>Comparison Between Amniotic Fluid Lamellar Body Count and Fetal Pulmonary Artery Doppler Indices in Predicting Fetal Lung Maturity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will study 200 women with singleton pregnancies presented with prelabor
      preterm rupture of membranes or undergoing cesarean section (CS). Amniotic fluid lamellar
      body count (LBC) and fetal pulmonary artery Doppler will be done to all women. LBC and fetal
      pulmonary artery Doppler will be correlated with fetal outcome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neonatal respiratory distress syndrome (RDS) remains a major cause of neonatal morbidity and
      mortality. A recent epidemiologic study in the United States estimates that there are 80,000
      cases of neonatal RDS each year, resulting in 8500 deaths and hospital costs in excess of
      $4.4 billion.

      A number of biochemical tests have been developed to predict the risk of RDS and assist
      obstetric care providers in delivery timing. Amniotic fluid lamellar body count (LBC) is an
      important biophysical test, based on measuring the concentration of pulmonary surfactant in
      amniotic fluid. It can be effectively used to assess fetal lung maturity. A noninvasive test
      for fetal lung maturity (FLM) would be useful to minimize the need for invasive testing and
      would be more acceptable to women. Fetal pulmonary artery Doppler waveform
      acceleration/ejection time may provide a noninvasive means of determining fetal lung maturity
      with relatively acceptable levels of sensitivity, specificity, and predictive values.

      The investigators will study 200 women with singleton pregnancies presented with prelabor
      preterm rupture of membranes or undergoing cesarean section (CS). Amniotic fluid lamellar
      body count (LBC) and fetal pulmonary artery Doppler will be done to all women. LBC and fetal
      pulmonary artery Doppler will be correlated with fetal outcome.

      Quantitative data will be statistically represented in terms of mean ± standard deviation (±
      SD) while categorical data will be represented as frequency and percentage. Comparison of
      quantitative data will be done using Mann Whitney U test for independent samples while
      categorical data will compared using Chi squared test or Fisher exact test when appropriate.
      A probability value (p value) less than 0.05 will be considered significant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory distress syndrome (RDS)</measure>
    <time_frame>1 day after delivery</time_frame>
    <description>RDS will be diagnosed clinically by the presence of tachypnea, working respiratory muscles, expiratory grunt, and chest x-ray.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for incubation</measure>
    <time_frame>1 day after delivery</time_frame>
    <description>It will be recorded if the pediatrician decides to incubate the neonate. The reason for incubation e.g. ventilation, hypoxia, ischemia will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Preterm Labour</condition>
  <arm_group>
    <arm_group_label>preterm labour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 women with preterm prelabour ruptured membranes or undergoing preterm CS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Amniotic fluid lamellar body count</intervention_name>
    <description>The LBC (the unit of measurement is number of lamellar bodies counted per microliter of amniotic fluid) will be determined using the platelet channels on the Hematology Flow Cytometer.</description>
    <arm_group_label>preterm labour</arm_group_label>
    <other_name>Amniotic fluid lamellar body count will be measured</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fetal pulmonary artery Doppler</intervention_name>
    <description>A fetal pulmonary artery Doppler will be performed using color Doppler ultrasound. Doppler flow velocity measurements, including systolic/diastolic ratio, pulsatility index, resistance index, and acceleration-time/ejection-time ratio using spectral Doppler ultrasound.</description>
    <arm_group_label>preterm labour</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancies without any major congenital anomalies.

          -  Gestation between 32-36 weeks

          -  Women presenting preterm pre-labour ruptured membranes or undergoing a cesarean
             section.

        Exclusion Criteria:

          -  Patients with major fetal anomalies.

          -  Bloody or meconium stained amniotic fluid

          -  preexisting maternal medical conditions (eg, diabetes, renal disease, hypertensive
             disorders, vaginal bleeding
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>AbdelGany MA Hassan, MRCOG, MD</last_name>
    <phone>+201017801604</phone>
    <email>abdelgany2@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Al Galaa maternity fospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Wafeek</last_name>
      <phone>002 01223524286</phone>
    </contact>
    <investigator>
      <last_name>Mohamed Wafeek</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cairo university hospitals</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AbdelGany Hassan, MRCOG, MD</last_name>
      <phone>002 01017801604</phone>
      <email>abdelgany2@gmail.com</email>
    </contact>
    <investigator>
      <last_name>AbdelGany MA Hassan, MRCOG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sherif Negm, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Doaa Salah, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>AVERY ME, MEAD J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959 May;97(5, Part 1):517-23.</citation>
    <PMID>13649082</PMID>
  </reference>
  <reference>
    <citation>Dubin SB. Characterization of amniotic fluid lamellar bodies by resistive-pulse counting: relationship to measures of fetal lung maturity. Clin Chem. 1989 Apr;35(4):612-6.</citation>
    <PMID>2702746</PMID>
  </reference>
  <reference>
    <citation>Neerhof MG, Dohnal JC, Ashwood ER, Lee IS, Anceschi MM. Lamellar body counts: a consensus on protocol. Obstet Gynecol. 2001 Feb;97(2):318-20. Review.</citation>
    <PMID>11165603</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2014</study_first_submitted>
  <study_first_submitted_qc>January 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2015</study_first_posted>
  <last_update_submitted>January 20, 2017</last_update_submitted>
  <last_update_submitted_qc>January 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>AbdelGany Hassan</investigator_full_name>
    <investigator_title>Lecturer of Gynecology and Obstetrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

